LAXMIDENTL
Laxmi Dental Limited (LAXMIDENTL) Stock Analysis
Laxmi Dental Limited is an Indian dental products company manufacturing and distributing consumables, equipment, and related products for dentists and labs. It serves clinics and institutional buyers through distributors. Growth is supported by rising dental care awareness in India. It is listed on Indian stock exchanges.
Healthcare › Medical Instruments & Supplies
₹184.70
-5.72% 1W | -37.00% 52W
Market Cap
1.0k CR
P/E Ratio
32.8
52W High
₹344.8
52W Low
₹155.9
Div. Yield
0%
Beta
–
50 DMA
₹198.3
200 DMA
₹204.9
Profit Margin
10.8%
Inst. Own.
16.3%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 48 | 55 | 60 | 57 | 62 | 61 | 66 | 72 | 66 | 74 | 75 |
| Expenses | 44 | 43 | 46 | 48 | 52 | 51 | 54 | 61 | 59 | 60 | 60 |
| Operating Profit | 4 | 12 | 14 | 9 | 10 | 10 | 12 | 11 | 7 | 14 | 14 |
| OPM % | 8% | 21% | 23% | 15% | 16% | 16% | 18% | 15% | 11% | 18% | 19% |
| Other Income | -0 | -0 | 6 | 1 | 1 | 2 | 2 | 2 | -4 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | -1 | 7 | 16 | 5 | 5 | 6 | 10 | 9 | -1 | 11 | 12 |
| Tax % | -140% | 16% | 11% | 23% | 23% | 41% | 24% | 20% | -175% | 4% | 21% |
| Net Profit | 2 | 8 | 17 | 6 | 5 | 4 | 8 | 9 | 2 | 10 | 10 |
| EPS in Rs | 0.84 | 2.78 | 6.04 | 2.12 | 0.93 | 0.78 | 1.53 | 1.55 | 0.36 | 1.83 | 1.87 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 92 | 137 | 162 | 194 | 239 | 278 | 287 |
| Expenses | 146 | 88 | 130 | 152 | 169 | 196 | 234 | 241 |
| Operating Profit | 3 | 4 | 7 | 9 | 24 | 43 | 44 | 46 |
| OPM % | 2.3% | 4.6% | 4.8% | 6% | 13% | 18% | 16% | 16% |
| Other Income | 2 | 0 | -10 | 2 | 0 | 10 | 3 | 3 |
| Interest | 3 | 3 | 4 | 4 | 6 | 6 | 2 | 1 |
| Depreciation | 7 | 6 | 8 | 11 | 12 | 15 | 16 | 17 |
| Profit before tax | -4 | -4 | -16 | -5 | 7 | 31 | 29 | 31 |
| Tax % | 5% | 8% | 15% | 4% | -136% | 21% | 9% | |
| Net Profit | -5 | -5 | -19 | -4 | 25 | 32 | 29 | 31 |
| EPS in Rs | -1.77 | -1.78 | -6.80 | -1.47 | 9.18 | 5.78 | 5.27 | 5.61 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 20.0% | 25.0% | – |
| Profit CAGR | 124.0% | 103.0% | – |
Shareholding Pattern
Promoters41.70%
FIIs33.59%
DIIs14.30%
Public10.39%
Promoters41.70%
FIIs32.39%
DIIs11.85%
Public14.05%
Promoters41.70%
FIIs32.45%
DIIs10.82%
Public15.01%
Promoters41.77%
FIIs31.20%
DIIs10.52%
Public16.50%
Promoters41.80%
FIIs30.10%
DIIs10.89%
Public17.21%
Promoters41.70%
FIIs34.24%
DIIs12.86%
Public11.19%
Promoters41.77%
FIIs31.20%
DIIs10.52%
Public16.50%
Promoters41.80%
FIIs30.10%
DIIs10.89%
Public17.21%
LAXMIDENTL
Holdings Analysis
Key strengths & risk signals
60
Overall
71
Fundamental
49
Technical
Risks (4)
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
POOR YEAR! Stock declined 37.0% in the last year.
WEAK POSITION! Current price (184.7) is below both moving averages.
WEAK! Trading at 15.2% of 52W range - near yearly lows.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 73,143 vs down days: 59,724. Ratio: 1.22x
APPROACHING OVERSOLD! RSI at 35.9 - watch for reversal.
MARKET ALIGNED! Beta of 1.00 - moves with the market.
Fundamental & Technical Analysis
60Overall
71Fundamental
49Technical
Fundamental Breakdown
Growth Quality
15/30
Revenue CAGR: 19.5% (VERY GOOD, 13/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
5/10
DECENT EFFICIENCY! 10.8% profit margin - acceptable profitability.
PEG Valuation
8/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 11.19% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (198.3) is below 200-day average (204.9) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (184.7) is below both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
0/10
POOR YEAR! Stock declined 37.0% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 73,143 vs down days: 59,724. Ratio: 1.22x
RSI
4/5
APPROACHING OVERSOLD! RSI at 35.9 - watch for reversal.
52W Range
1/5
WEAK! Trading at 15.2% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 5.7% (1 week), 5.5% (1 month), 16.6% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
LAXMIDENTL
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-30 | Concall PDF | |
| Q3FY262026-02-17 | Concall PDF | |
| Q2FY262025-11-18 | Concall PDF |
Peer Comparison
Healthcare · Medical Instruments & Supplies · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAXMIDENTL | ₹184.70 | 32.8 | 10.8% | 19.5% | – | -37.0% | 60 | APPROACHING SUPPORT | +22.6% | +2.0% | +13.5% | +1.1% |
| TARSONS | ₹331.20 | 158.5 | 2.5% | 14.3% | -43.8% | +16.2% | 67 | BREAKOUT | -177.8% | -133.3% | +20.6% | -8.9% |
| AGARWALEYE | ₹465.80 | 100.2 | 6.7% | 26.9% | 12.3% | -14.3% | 79 | BREAKDOWN | +50.7% | +13.9% | +26.0% | +8.8% |
| POLYMED | ₹1,593.80 | 51.3 | 15.8% | 19.1% | 22.7% | -16.9% | 65 | APPROACHING SUPPORT | -7.6% | +32.3% | +30.3% | -1.7% |
| LENSKART | ₹646.50 | 178.6 | 6.8% | 35.4% | 67.0% | +59.4% | 60 | BREAKDOWN | +269.1% | +10.7% | +43.3% | +7.9% |
| THEMISMED | ₹106.50 | 24.6 | 12.1% | -0.4% | -72.8% | -14.1% | 53 | BREAKDOWN | -273.2% | +176.4% | -10.9% | +13.7% |
| HEALTHX | ₹283.80 | – | -1.3% | 8.0% | – | -6.3% | 51 | APPROACHING RESISTANCE | -89.5% | -122.3% | +58.1% | +16.4% |
| BAFNAPH | ₹461.40 | 140.2 | 5.5% | 9.3% | -0.7% | +208.2% | 63 | BREAKOUT | -97.1% | -96.3% | -23.1% | -37.0% |
Data from TradeAlone · Updated daily
